Skip to main content
Ascletis Pharma Inc. logo

Ascletis Pharma Inc. — Investor Relations & Filings

Ticker · 1672 ISIN · KYG0520K1094 LEI · 254900SKEFCO9I3GPL05 HKEX Manufacturing
Open in API
Filings indexed 1,474 across all filing types
Latest filing 2019-01-02 Share Issue/Capital Cha…
Country KY Cayman Islands
Listing HKEX 1672

About Ascletis Pharma Inc.

http://www.ascletis.com

Ascletis Pharma Inc. is a fully integrated, R&D driven biotechnology company dedicated to the development and commercialization of potential best-in-class and first-in-class therapeutics. The company covers the entire value chain from discovery to sales. Ascletis primarily focuses on metabolic diseases, including chronic weight management, utilizing proprietary platforms such as Artificial Intelligence-assisted Structure-Based Drug Discovery (AISBDD), Ultra-Long-Acting Platform (ULAP), and Peptide Oral Transport ENhancement Technology (POTENT). Key pipeline candidates include ASC30 (oral/subcutaneous GLP-1R agonist), ASC35 (GLP-1R/GIPR dual agonist), ASC36 (amylin receptor agonist), and ASC37 (GLP-1R/GIPR/GCGR triple agonist). The company also maintains active programs in viral diseases, NASH/PBC, and oncology.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on movements in Securities for the month ended 31 December 2018
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/12/2018, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share capital changes. The content is focused on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a capital or shareholding update. Given the detailed nature of share capital movements and the monthly frequency, this fits best under the category 'Share Issue/Capital Change (SHA)' which covers announcements regarding new share issues, stock splits, or other capital changes. The document is substantive and not merely an announcement of a report, so it is not RPA or RNS. Therefore, the classification is SHA with high confidence.
2019-01-02 English
AUDIT COMMITTEE - TERMS OF REFERENCE
Governance Information Classification · 95% confidence The document is titled 'AUDIT COMMITTEE - TERMS OF REFERENCE AMENDED AND ADOPTED BY THE BOARD OF DIRECTORS OF THE COMPANY' and details the composition, duties, powers, meetings, and authority of the Audit Committee. It does not contain any financial statements, audit results, or financial performance data. Instead, it outlines governance and procedural rules related to the audit committee's role in overseeing financial reporting and internal controls. This type of document is a governance-related report describing internal rules and committee responsibilities rather than an audit report or annual report. Therefore, the most appropriate classification is Governance Information (CGR). The document length is substantial (11,987 characters), indicating it is a full terms of reference document, not a brief announcement or certification.
2018-12-27 English
NOMINATION COMMITTEE - TERMS OF REFERENCE
Governance Information Classification · 100% confidence The document is titled 'Nomination Committee - Terms of Reference Amended and Adopted by the Board of Directors' and details the structure, roles, duties, meeting procedures, and authority of the Nomination Committee. It is a governance-related document focusing on board composition, nomination policies, and committee operations. There is no financial data, earnings information, or regulatory filing content. It is not an announcement or report of financial results or voting outcomes. This fits the category of Governance Information, which covers internal rules, board structure, and governance practices.
2018-12-27 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information Classification · 95% confidence The document is an announcement listing the members of the board of directors and their roles and functions, including committee memberships. It is dated and signed by the board. There is no financial data, no discussion of financial results, no mention of annual or interim reports, no voting results, no legal proceedings, no capital changes, and no other report content. The document is clearly about the composition and structure of the board and its committees. This fits the definition of Board/Management Information (MANG), which covers announcements of changes or information about the company's board of directors or senior management. The document length is short (1624 characters), and it is not a report publication announcement or a certification. Therefore, the correct classification is MANG with high confidence.
2018-12-24 English
RESIGNATION OF NON-EXECUTIVE DIRECTOR
Board/Management Information Classification · 100% confidence The document is an announcement from Ascletis Pharma Inc. regarding the resignation of a non-executive director, Mr. Wei Fu. It details the resignation date, reasons, and confirms no disagreements or other matters to report. There is no financial data, no report attached or referenced, and no mention of any other type of filing such as financial results or governance reports beyond the director change. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2018-12-24 English
Monthly Return of Equity Issuer on movements in Securities for the month ended 30 November 2018
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/11/2018, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other movements in issued share capital. The content focuses on changes in share capital and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month. The document length is 13,686 characters, which is substantive and contains detailed data. This type of document corresponds to a regulatory announcement about share capital changes rather than a full financial report or earnings release. Therefore, the most appropriate classification is 'Share Issue/Capital Change' (SHA).
2018-12-04 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.